Tramadol Use in Renal Insufficiency

Introduction to Tramadol Use

• The American Society of Clinical Oncology (ASCO) and the American College of Physicians recommend that tramadol be avoided in patients with severe renal insufficiency (eGFR <30 mL/min) and end-stage renal disease, unless no alternatives exist 1, 3
• The accumulation of the parent drug and its active metabolite M1 significantly increases the risk of seizures, respiratory depression, and serotonin syndrome in patients with renal insufficiency 1, 2

Recommendations Based on Degree of Renal Insufficiency

• The National Kidney Foundation suggests initiating tramadol at 50 mg one or two times a day, titrating slowly with increments of 50 mg/day in divided doses every 3-7 days as tolerated, in patients with mild to moderate renal insufficiency (eGFR ≥30 mL/min) 3
• The maximum dose should be significantly reduced, not exceeding 200 mg/day in immediate-release formulations, in patients with mild to moderate renal insufficiency (eGFR ≥30 mL/min) 2, 3

Risks and Warnings

• The Association of Anaesthetists of Great Britain and Ireland recommends avoiding tramadol in patients with renal dysfunction during perioperative management 4
• The American College of Physicians recommends avoiding combination of tramadol with selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs), or monoamine oxidase inhibitors (MAOIs) due to the high risk of serotonin syndrome 1, 2, 3

Safe Alternatives in Renal Insufficiency

• The American Society of Clinical Oncology (ASCO) recommends paracetamol (acetaminophen) as the first-line analgesic for mild to moderate pain, safe up to 4 grams/24 hours in adults with end-stage renal disease 1
• Fentanyl is considered a safe option for severe renal insufficiency, with hepatic metabolism and no active renal metabolites 1
• Buprenorphine (transdermal or IV) is a second safe option, with a favorable pharmacokinetic profile 1

Opioids to be Avoided Completely

• Morphine, codeine, and meperidine are contraindicated due to accumulation of neurotoxic metabolites 1
• Morphine should be avoided if creatinine clearance is <30 mL/min due to accumulation of morphine-6-glucuronide 5
• Codeine should not be administered due to its constipating, emetic, and cognitive dysfunction-associated effects 4